Dermatology patients living in the most disadvantaged neighborhoods were three times more likely to receive a diagnosis of ...

Heightened exposure levels to particulate matter before COVID-19 hospitalization raised the odds for poor outcomes in ...

Researchers projected CT use in 2023 would lead to more than 100,000 future cancer diagnoses, and if trends continued, may ...

Careful examination of clinical trial data and a better understanding of risk factors can help rheumatologists determine if a ...

As recently as March, the FDA approved the IL-23 inhibitor guselkumab (Tremfya, Johnson & Johnson/Janssen) for patients with Crohn’s disease, offering both IV and subcutaneous induction options.

Immunoengineering, which has been beneficial to other medical specialties, could be used in the infectious diseases field to ...

When we are looking at the role of a mental health professional, we are bridging this gap between physical healing and ...

CeraVe and Neutrogena over-the-counter products topped the U.S. News & World Report third annual Best OTC Medicine & Health ...

Treatment with stimulants is unlikely to cause psychotic symptoms in children with ADHD, according to a new study published ...

Annual universal depression screening for adolescents during primary care visits is cost effective, especially for certain ...

The U.S. and China reached an agreement that will temporarily lower the recent high tariffs on Chinese goods, including Chinese-origin eye wear products, according to a Vision Council press release.

In this video, Ursula A. Matulonis, MD, shares that although data from the REFRaME-O1 trial of luveltamab tazevibulin were presented at Society of Gynecologic Oncology Annual Meeting on Women’s Cancer ...